[Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study]
Antonio Coca1, Antonio Dalfó, Enric Esmatjes
1Instituto de Medicina y Dermatología, Hospital Clínic, IDIBAPS, Universidad de Barcelona, Barcelona, Spain. acoca@clinic.ub.es
Insights
Cardiovascular risk factor treatment in Spain was common but varied, with type 2 diabetes, previous cardiovascular disease, and obesity linked to poor blood pressure control.
Area of Science:
- Cardiology
- Primary Care
- Public Health
Background:
- The PREVENCAT study assessed cardiovascular risk factor (CVRF) control and treatment in Spanish primary care.
- Focus on patients with hypertension (HT), type 2 diabetes mellitus (DM2), or hypercholesterolemia (HC).
Purpose of the Study:
- To estimate the control of main CVRF and their treatment.
- Analyze predictors associated with CVRF control in a primary care setting.
Main Methods:
- Cross-sectional study design.
- Recruitment of patients with HT, DM2, and/or HC.
- Description and analysis of treatments and CVRF control predictors.
Main Results:
- High treatment rates for HT (95%), DM2 (84%), and HC (71.4%).
- Common drugs: diuretics, sulfonylureas, statins. Monotherapy frequent for HT.
- DM2, previous CVD, obesity, and sedentarism predicted poor blood pressure control.
Conclusions:
- CVRF treatment was prevalent but heterogeneous and not always evidence-based.
- Type 2 diabetes, previous cardiovascular disease, and obesity were associated with inadequate blood pressure control.
Background And Objective:
The PREVENCAT study was designed to estimate the control of the main cardiovascular risk factors (CVRF) and their treatment in a sample of population having the diagnoses of hypertension (HT), type 2 diabetes mellitus (DM2) or hypercholesterolemia (HC) who was attended by primary care physicians in Spain.
Patients And Method:
Cross-sectional study in patients with HT, DM2 and/or HC, who were consecutively recruited. We describe the treatments for HT, DM2 and HC and analyze and the association between several potential predictors and the control of these CVRF.
Results:
2,649 patients were included in the study. 95% of HT patients were under treatment, as were 84% of DM2 and 71.4% of HC patients; most common drugs were diuretics, sulphonylureas and statins, respectively. Monotherapy was more frequent than combined therapy for hypertension treatment. The frequency of HT and DM2 treatment was similar among the subgroups defined by the presence or absence of the other two diagnoses. However, HC treatment was more common in the presence of DM2 (p = 0.001). Age, previous cardiovascular disease (CVD), DM2, obesity and sedentarism were all predictors of poor blood pressure control despite drug treatment. Age, previous CVD, HT and sedentarism were predictors of poor HC control.
Conclusions:
CVRF treatment was high although heterogeneous and not based on the best available evidence. DM2, previous CVD and obesity were associated with insufficient blood pressure control.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Preventive Healthcare Services
Peripheral Artery Disease III: Interprofessional Care
Hypertension IV: Drug Therapy and Lifestyle Modifications
